The incidence of cancer among acromegaly patients: Results from the German acromegaly registry

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 10, 2015, Pages 3894-3902

  Petroff, David ^a   Tönjes, Anke ^b   Grussendorf, Martin ^c   Droste, Michael ^d   Dimopoulou, Christina ^e   Stalla, Günter ^e   Jaursch Hancke, Cornelia ^f   Mai, Manuel ^b   Schopohl, Jochen ^g   Schöfl, Christof ^h  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c Center of Endocrinology and Diabetes   (Germany)

^d Endocrine Practice   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

ACROMEGALY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GERMANY; HORMONE BLOOD LEVEL; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; ONSET AGE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; THYROID CANCER; BLOOD; INCIDENCE; METABOLISM; MIDDLE AGED; NEOPLASMS; REGISTER;

ACROMEGALY; ADULT; AGED; FEMALE; GERMANY; HUMAN GROWTH HORMONE; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES;

EID: 84943790290     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2372     Document Type: Article

References (34)

1. Barzilay J, Heatley GJ, Cushing GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med. 1991;151:1629-1632.
2. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF Jr. Acromegaly and gastrointestinal cancer. Cancer. 1991;68:1673-1677.
3. Orme SM, McNally RJ, Cartwright RA, Belchetz PE for the United Kingdom Acromegaly Study Group. Mortality and cancer incidence in acromegaly: A retrospective cohort study. J Clin Endocrinol Metab. 1998;83:2730-2734.
4. Popovic V, Damjanovic S, Micic D, et al. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin Endocrinol (Oxf). 1998;49:441-445.
5. Baris D, Gridley G, Ron E, et al. Acromegaly and cancer risk: A cohort study in Sweden and Denmark. Cancer Causes Control. 2002;13:395-400.
6. Kauppinen-Mäkelin R, Sane T, Välimäki MJ, et al. Increased cancer incidence in acromegaly-A nationwide survey. Clin Endocrinol (Oxf). 2010;72:278-279.
7. Brunner JE, Johnson CC, Zafar S, Peterson EL, Brunner JF, Mellinger RC. Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol (Oxf). 1990;32:65-71.
8. Kurimoto M, Fukuda I, Hizuka N, Takano K. The prevalence of benign and malignant tumors in patients with acromegaly at a single institute. Endocr J. 2008;55:67-71.
9. Colao A, Balzano A, Ferone D, et al. Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf). 1997;47:23-28.
10. Jenkins PJ, Fairclough PD, Richards T, et al. Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf). 1997;47:17-22.
11. Matano Y, Okada T, Suzuki A, Yoneda T, Takeda Y, Mabuchi H. Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels. Am J Gastroenterol. 2005;100:1154-1160.
12. Terzolo M, Reimondo G, Gasperi M, et al. Colonoscopic screening and follow-up in patients with acromegaly: A multicenter study in Italy. J Clin Endocrinol Metab. 2005;90:84-90.
13. Gasperi M, Martino E, Manetti L, et al. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian Multi-center Study. J Endocrinol Invest. 2002;25:240-245.
14. Herrmann BL, Baumann H, Janssen OE, Görges R, Schmid KW, Mann K. Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up. Exp Clin Endocrinol Diabetes. 2004;112:225-230.
15. dos Santos MC, Nascimento GC, Nascimento AG, et al. Thyroid cancer in patients with acromegaly: A case-control study. Pituitary. 2013;16:109-114.
16. Renehan AG, Brennan BM. Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endocrinol Metab. 2008;22:639-657.
17. Renehan AG, O'Connell J, O'Halloran D, et al. Acromegaly and colorectal cancer: A comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res. 2003; 35:712-725.
18. Loeper S, Ezzat S. Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord. 2008;9:41-58.
19. Reincke M, Petersenn S, Buchfelder M, et al. The German Acromegaly Registry: description of the database and initial results. Exp Clin Endocrinol Diabetes. 2006;114:498-505.
20. Schöfl C, Franz H, Grussendorf M, et al. Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. Eur J Endocrinol. 2013;168:39-47.
21. German Centre for Cancer Registry Data. Spreadsheet with data on incidence and prevalence of colorectal cancer. www.krebsdaten.de/Krebs/SharedDocs/Downloads/Lokalisationen-xls/C18-21.xls? Blob-publicationFile.
22. Wienecke A, Barnes B, Lampert T, Kraywinkel K. Changes in cancer incidence attributable to tobacco smoking in Germany, 1999-2008. Int J Cancer. 2014;134:682-691.
23. Haberland J, Bertz J, Wolf U, Ziese T, Kurth BM. German cancer statistics 2004. BMC Cancer. 2010;10:52.
24. Molitch ME. Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am. 1992;21:597-614.
25. Garwood F. Fiducial limits for the Poisson distribution. Biometrika. 1936;28:437-442.
26. Breslow NE, Day NE. Statistical Methods in Cancer Research: Volume II-The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 82. Lyon, France: International Agency for Research on Cancer; 1987.
27. Gullu BE, Celik O, Gazioglu N, Kadioglu P. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary. 2010; 13:242-248.
28. Dagdelen S, Cinar N, Erbas T. Increased thyroid cancer risk in acromegaly. Pituitary. 2014;17:299-306.
29. DąbrowskaAM,Tarach JS, KurowskaM,Nowakowski A. Thyroid diseases in patients with acromegaly. Arch Med Sci. 2014;10:837-845.
30. Leenhardt L, Grosclaude P, Chérié-Challine L. Increased incidence of thyroid carcinoma in France: A true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid. 2004;14:1056-1060.
31. Colonna M, Grosclaude P, Remontet L, et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer. 2002;38:1762-1768.
32. Bates AS, Van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med. 1993;86:293-299.
33. Giustina A, Chanson P, Bronstein MD, et al.Aconsensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010;95:3141-3148.
34. Giustina A, Chanson P, Kleinberg D, et al. Expert consensus document: A consensus on the medical treatment of acromegaly. Nat Rev Endocrinol. 2014;10:243-248.